| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ANA.410280103 |
| P8608 | Fatcat ID | release_6atqc52rmfaatobrbr2ahujobu |
| P698 | PubMed publication ID | 1973889 |
| P2093 | author name string | Plaitakis A | |
| P2860 | cites work | Glutamate dehydrogenase and aspartate aminotransferase in leukocytes of patients with motor neuron disease | Q45238051 |
| Brain glutamate deficiency in amyotrophic lateral sclerosis | Q48180224 | ||
| Glutamate or aspartate as a possible neurotransmitter of cerebral corticofugal fibers in the monkey | Q48722743 | ||
| P433 | issue | 1 | |
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| P304 | page(s) | 3-8 | |
| P577 | publication date | 1990-07-01 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis | |
| P478 | volume | 28 |
| Q33590608 | A pilot trial of dextromethorphan in amyotrophic lateral sclerosis |
| Q70764371 | A scientific rationale for protective therapy in Parkinson's disease |
| Q41743616 | A summary of mechanistic hypotheses of gabapentin pharmacology |
| Q44893940 | AMPA receptor activation, but not the accumulation of endogenous extracellular glutamate, induces paralysis and motor neuron death in rat spinal cord in vivo. |
| Q70507471 | Abnormal glycine metabolism in motor neurone disease: studies on plasma and cerebrospinal fluid |
| Q38575783 | Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach |
| Q40959519 | Amyotrophic lateral sclerosis: current and future treatment strategies |
| Q74764667 | Blood glutamate levels in patients with motor neuron disease |
| Q71795815 | Cellular and Subcellular Distribution of NMDAR1 Splice Variant mRNA in the Rat Lumbar Spinal Cord |
| Q40783837 | Cholinergic systems: human diseases, animal models, and prospects for therapy. |
| Q36216333 | Chromosomal localization of glutamate receptor genes: relationship to familial amyotrophic lateral sclerosis and other neurological disorders of mice and humans |
| Q37160164 | Compartmentalization of excitatory amino acid receptors in human striatum |
| Q42809601 | Continuous c-fos expression precedes programmed cell death in vivo |
| Q48342549 | Cortical excitability in amyotrophic lateral sclerosis: a clue to pathogenesis. |
| Q71980862 | Diagnostic value of GM 1 antibodies in motor neuron disorders and neuropathies |
| Q48387929 | Double magnetic stimulation of the motor cortex in amyotrophic lateral sclerosis |
| Q47730758 | Effect of neonatal monosodium glutamate on the activities of glutamate dehydrogenase and aminotransferases in the circumventricular organs of rat brain |
| Q44625348 | Effects of 2-[N-(4-Chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an Orally Active α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist, in Models of Generalized Epileptic Seizure in Mice and Rats |
| Q46581820 | Enhancement of single motor unit inhibitory responses to transcranial magnetic stimulation in amyotrophic lateral sclerosis |
| Q52047474 | Excitotoxicity in the embryonic chick spinal cord |
| Q35830648 | Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis |
| Q34847712 | Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis |
| Q37071898 | Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice: a quantitative confocal analysis |
| Q37428498 | Hereditary canine spinal muscular atrophy: an animal model of motor neuron disease |
| Q48604044 | Immunoglobulins from motoneurone disease patients enhance glutamate release from rat hippocampal neurones in culture |
| Q41074664 | Immunohistochemical localization of the neuron-specific glutamate transporter EAAC1 (EAAT3) in rat brain and spinal cord revealed by a novel monoclonal antibody |
| Q46890621 | Impaired glutamate transport in a mouse model of tau pathology in astrocytes. |
| Q27687333 | Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis |
| Q41471729 | Intracellular signal modulation: a pivotal role for protein kinase C. |
| Q72679228 | Lactate dehydrogenase and glutamate dehydrogenase activities in the circumventricular organs of rat brain following neonatal monosodium glutamate |
| Q89250631 | Localization of Human Glutamate Dehydrogenases Provides Insights into Their Metabolic Role and Their Involvement in Disease Processes |
| Q33185437 | Low concentrations of glutamate induce apoptosis in cultured neurons: implications for amyotrophic lateral sclerosis |
| Q57479119 | Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons |
| Q71798603 | Modulation of NMDA receptor expression in the rat spinal cord by peripheral nerve injury and adrenal medullary grafting |
| Q37824455 | NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: modeling a molecular mechanism |
| Q77668732 | Neuropharmacology of AMPA and kainate receptors |
| Q38868221 | Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis |
| Q51825896 | Omics to Explore Amyotrophic Lateral Sclerosis Evolution: the Central Role of Arginine and Proline Metabolism. |
| Q40434971 | Oxidative stress: its role in the pathogenesis of amyotrophic lateral sclerosis |
| Q48241885 | Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease |
| Q46199099 | Platelet Glycine, Glutamate and Aspartate in Primary Headache |
| Q93079386 | Prediagnostic plasma branched-chain amino acids and the risk of amyotrophic lateral sclerosis |
| Q48399254 | Pregnenolone sulfate exacerbates NMDA-induced death of hippocampal neurons |
| Q73345905 | Riluzole does not have an acute effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis |
| Q28586274 | Synaptosomal glutamate uptake declines progressively in the spinal cord of a mutant mouse with motor neuron disease |
| Q36799584 | Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers |
| Q41534665 | Therapeutic advances in amyotrophic lateral sclerosis |
| Q40408954 | Therapeutic developments in amyotrophic lateral sclerosis |
| Q43809083 | Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels |
| Q92512249 | Using transcription factors for direct reprogramming of neurons in vitro |
| Q48581349 | Vascular changes in the spinal cord in N-methyl-D-aspartate-induced excitotoxicity: morphological and permeability studies |
| Q45257760 | What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? |
| Q41813091 | δ-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes |
Search more.